Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05037370 · ClinicalTrials.gov registry record · NA
CONTOURA vs WFO Ablation PRK & LASIK
A NA study of Refractive Surgery, sponsored by 59th Medical Wing.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT05037370 is a NA study of Refractive Surgery that is actively recruiting participants, run by 59th Medical Wing. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05037370, a NA study of Refractive Surgery, is actively recruiting participants, sponsored by 59th Medical Wing.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective randomized contralateral double-masked study. Each patient will be randomized as to which eye undergoes wave-front optimized (WFO) vs. wave-front guided (WFG) during Photorefractive keratectomy (PRK) or Laser-assisted in situ Keratomileusis (LASIK) surgery to determine which ablation profile provides the best visual outcome.
Conditions Studied
Interventions
- DEVICE Wave-Front Optimized (WFO) ablation vs Topography-guided (TG) ablation
Study Locations (1)
Texas
- Joint Warfighter Refractive Surgery Center at WHASC - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2021-04-22 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05037370
The ClinicalTrials.gov registry entry for NCT05037370 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 59th Medical Wing, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Refractive Surgery appearing as the primary indexed condition, and to 1 intervention - of which Wave-Front Optimized (WFO) ablation vs Topography-guided (TG) ablation is the first listed.
NCT05037370 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05037370 about?
NCT05037370 is a clinical study titled "CONTOURA vs WFO Ablation PRK & LASIK". This is a prospective randomized contralateral double-masked study. Each patient will be randomized as to which eye undergoes wave-front optimized (WFO) vs. wave-front guided (WFG) during Photorefractive keratectomy (PRK) or Laser-assisted in situ Keratomileusis (LASIK) surgery to determine which ab...
What is the current status of trial NCT05037370?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2021-04-22. Estimated completion is 2026-12-31.
What conditions does trial NCT05037370 study?
This clinical trial studies the following conditions: Refractive Surgery.
What interventions are being tested in trial NCT05037370?
The interventions under investigation include: Wave-Front Optimized (WFO) ablation vs Topography-guided (TG) ablation (DEVICE).
Who is sponsoring clinical trial NCT05037370?
This trial is sponsored by 59th Medical Wing, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05037370 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Refractive Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluate the Safety and Effectiveness of the AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery
RECRUITING · NA
-
Evaluation of the Aspheric ReSTOR Intraocular Lens (IOL) After Routine Cataract Extraction
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.